Menu ☰

paterlini brechot

Patrizia Paterlini Bréchot, Centre National de la Recherche Scientifique / French National Centre for Scientific Research, INSERM, Université Paris Descartes Department, Faculty Member. Studies Immunology, Reproductive Biology, and Cellular

Find showtimes, watch trailers, browse photos, track your Watchlist and rate your favorite movies and TV shows on your phone or tablet! IMDb Mobile site

patrizia paterlini-brechot m.d., phd Professor of Molecular and Cell Biology/Oncology Patrizia Paterlini-Bréchot is a Professor of Cellular and Molecular Biology at the University Paris Descartes in Paris, France, and Hospital Practitioner at Assistance Publique-Hôpitaux de Paris.

Founder and Director, Rarecells Holdings, Inc. The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global.

The company was founded on April 11, 2001 by Patrizia Paterlini-Brechot, Ian Jones and Christian Brechot and is headquartered in Sarcelles, Fran ce. Other Affiliations. Patrizia Paterlini-Brechot is affiliated with Screencell SA, University of Paris V,

P. Paterlini-Brechot, N.L. Benali / Cancer Letters 253 (2007) 180–204 181 in organs, are mutually and extensively adherent by cell-to-cell and cell-to-extracellular matrix (ECM)

The event featured more than 100 of Davidtz-Sloane’s closest friends for a private reception for women to learn more about Dr. Barbara B. Hayden and Dr. Patrizia Paterlini-Brechot’s research and

Nous sommes heureux d’annoncer la sortie du livre “Tuer le cancer” du Prof Paterlini-Bréchot, qui décrit l’avancement des recherches pour faire reculer le cancer. Les recherches du Pr Paterlini Brechot sont soutenues par l’Association STL (Safe Tests for Life).

The ISET Test (Isolation by SizE of Tumor cells / Trophoblastic cells) is a diagnostic blood test that detects circulating tumor cells in a blood sample. The ISET technology was first reported in 2000 in the American Journal of Pathology by the team of Professor Patrizia Paterlini-Bréchot.

ISETbyRarecells : The ISET technology is the fruit of 20 years of research of Patrizia Paterlini-Brechot and her team at Université Paris Descartes and INSERM.

Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Author(s): Vona G, Sabile A, Louha M, Sitruk V, Romana S, Schütze K, Capron F, Franco D, Pazzagli M, Vekemans M, Lacour B, Bréchot C, Paterlini-Bréchot P

Learn about working at Rarecells Diagnostics. Join LinkedIn today for free. See who you know at Rarecells Diagnostics, leverage your professional network, and get hired.

Apr 12, 2016 · The ISET blood test is a revolutionary breakthrough in the field of cancer screening. Developed by French cancer specialist Patrizia Paterlini-Bréchot, based at the Necker-Enfants Malades Faculty of Medicine in Paris, the blood test allows the early detection of all forms of …

Hussein Mouawia, Ali Saker, Jean-Philippe Jais, Alexandra Benachi, Laurence Bussières, Bernard Lacour, Jean-Paul Bonnefont, René Frydman, Joe Leigh Simpson and Patrizia Paterlini-Brechot, Circulating trophoblastic cells provide genetic diagnosis in 63 fetuses at risk for cystic fibrosis or spinal muscular atrophy, Reproductive BioMedicine

Patrizia Paterlini-Brechot Professor of Oncology/Molecular Biology, University Paris Descartes. Jennifer Jones Staff Clinician, Molecular Immunogenetics & Vaccine Research Section, National Cancer Institute (NCI) Lucia Languino Professor of Cancer Biology, Thomas Jefferson University. Fred Kramer

Patrizia Paterlini-Brechot, PhD, MD, Cellular & Molecular Biology, University Paris Descartes, France. Premier Sponsor. View All Sponsors. Programs. 6 May Advances in Prenatal Molecular Diagnostics. 7-8 May Biomarkers for Immunotherapy. Advanced Diagnostics for Infectious Disease.

Diagnosticar o cancro mesmo antes de aparecerem os sintomas? Movida por esta ambição extraordinária, Patrizia Paterlini-Bréchot, médica oncologista e investigadora, transpôs todos os obstáculos e concebeu um teste verdadeiramente revolucionário.

Traditional bio: Prof. Patrizia Paterlini-Bréchot is Oncologist, Hematologist and Molecular Biologist. She is a Professor of Oncology/Molecular Biology at Paris Descartes University- Necker Hospital, with a triple task of research leader, academic teacher and hospital practitioner.

Circulating tumor cells are an important link between the spread of primary solid tumors and metastatic disease.

Spinal muscular atrophy (SMA) has a prevalence of one in 6000 births and a one in 40 heterozygote frequency. We aimed to develop a routine test for non-invasive prenatal diagnosis.

It looks like we don’t have any Biography for Patrizia Paterlini-Bréchot yet.. Be the first to contribute! Just click the “Edit page” button at the bottom of the page or learn more in the Biography submission guide.

Patrizia Paterlini-Brechot, Ph.D., M.D., Cellular & Molecular Biology, University Paris Descartes . Circulating fetal cells offer an interesting opportunity to analyze fetal DNA not mixed with maternal DNA aiming to develop a non-invasive approach for prenatal genetic diagnosis (NI-PND).

Patrizia Paterlini-Brechot: I think it’s improving noninvasive genetic diagnosis, their reliability, their validity for multiple genetic disorders at the same time, and their affordability. In few words: developing a true and valid noninvasive alternative to the invasive methods, amniocentesis and …

Patrizia Paterlini-Brechot, PhD, MD, Cellular & Molecular Biology, University Paris Descartes, France. Confined Placental and Fetal Mosaicism: Prevalence, Outcome and Impact on Non-Invasive Prenatal Testing Results. Ida Charlotte Bay Lund, MD, Department of Clinical Genetics, Center for Fetal Diagnostics, Aarhus University Hospital, Denmark.

J Thorac Dis 2013 Oct;5(5):593-9. Department of Anatomic Pathology, AC Camargo Cancer Hospital, São Paulo, Brazil; ; Department of Clinical Oncology, AC Camargo Cancer Hospital, São Paulo, Brazil;

P Paterlini-Brechot’s 1 research works with 9 citations and 8 reads, including: Effect of laparoscopy versus laparotomy on circulating tumor cells using isolation by size of epithelial tumor cells.

Patrizia Paterlini-Brechot is awarded the prestigious American society of cytopathology award for New Frontiers in Cytology. Publication Khoja L. et al Melanoma Res. 2014 Feb;24(1):40-6. Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanoma.

P PATERLINI-BRÉCHOT published 5 Research Articles on Carcinoma, Hepatocellular Liver Neoplasms Neoplastic Cells, Circulating Hepatitis B Hepatitis C Check More at

Patrizia Paterlini-Brechot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

Patrizia Paterlini-Brechot, PhD, MD, Cellular & Molecular Biology, University Paris Descartes. Isolation of rare trophoblastic cells from blood is a technical challenge with impact on the number of collected fetal cells and on the quality of their DNA.

Paterizia Brechot Overview Paterizia Paterlini Brechot has been associated with one company, according to public records. The company was incorporated in Texas eight …

We listened to two brilliant experts, Dr. Barbara Hayden, of the Sound Breast Institute in Santa Monica, and Dr. Patrizia Paterlini-Brechot, of the Université Paris Descartes, as they shared information about some of the more accurate and completely non-toxic options emerging in medicine. Traditionally, women have been offered mammography

Chronic hepatitis B virus (HBV) infection is a major risk factor for hepatocellular carcinoma (HCC). This review will summarize the current knowledge on the mechanisms involved …

PATRIZIA PATERLINI-BRÉCHOT published 5 Research Articles on Neoplasm Metastasis Neoplastic Cells, Circulating Neoplasms Neoplasm Invasiveness Liver Neoplasms Check More at

Isolation, detection, and immunomorphological characterization of circulating tumor cells (CTCs) from patients with different types of sarcoma using isolation by …

You have free access to this content Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely “occult”?

Published in: Hepatology · 2001Authors: Christian Brechot · Valerie Thiers · Dina Kremsdorf · B Nalpas · Stanislas Pol · Patrizi…Affiliation: Pasteur InstituteAbout: Molecular biology · Viral disease · Hepatocellular carcinoma · Hepatitis B virus · Quant…

New blood tests are being used in some cancer diagnoses. To mark World Cancer Day on February 4, we’ve taken a look at recent discoveries made in terms of detection and treatment.

“The ISET-CTC (Isolation of Circulating-Tumour-Cells from the blood) Test was developed by Professor Paterlini-Brechot in France about 20 years ago, is a cytology-based blood test using microscopy – a 100-year old clinically validated technique to identify cancer cells and used in …

Rarecells Holdings, Inc. company research & investing information. Find executives and the latest company news.

Rarecells® was founded in 2009 by Patrizia Paterlini-Brechot MD, PhD, Professor of Cell Biology and Oncology at University Paris Descartes Paris, France, to validate and commercialize the company

Patrizia Paterlini Bréchot is the author of Tuer Le Cancer (4.00 avg rating, 2 ratings, 1 review), Matar o Cancro (3.00 avg rating, 2 ratings, 0 reviews)


Patrizia Paterlini-Brechot, MD, PhD, is Oncologist, Hematologist and Molecular Biologist. She is a Professor of Oncology/Molecular Biology at Paris Descartes University- Necker Hospital, with a triple task of research leader, academic teacher and hospital practitioner.

The goal of the Journal of Laboratory and Precision Medicine is to provide a valuable platform for exchanging information in the multidisciplinary arena of precision laboratory medicine data.

Journal of Tumor Medicine & Prevention The mission of the Journal of Tumor Medicine & Prevention is the swift exchange of scientific information worldwide and seeks to publish high-quality practical Patrizia Paterlini-Brechot. University Paris Descartes France View Profile.

The ambition of the project WOMEN INFLUENCE COMMUNITY is to fully engage its members in the development of powerful women’s global influence. It aims to unite proactive female business-managers, thought-leaders, philosophers, mothers, artists, muses, investors and entrepreneurs.

La chercheuse Patrizia Paterlini-Bréchot veut prendre le cancer de vitesse. Grâce à son test Iset capable de repérer les signes avant-coureurs de la maladie par une simple prise de sang, elle

Patrizia Paterlini-Bréchot is the author of Uccidere il cancro (3.50 avg rating, 2 ratings, 1 review)


Patrizia Paterlini-Brechot Overview Patrizia Paterlini-Brechot has been associated with one company, according to public records. The company was incorporated in Texas seven years …


Paterlini-Brechot USOO7651838B2 (10) Patent No.: US 7.651,838 B2 (45) Date of Patent: Jan. 26, 2010 (54) PRENATAL DIAGNOSIS METHOD ON SOLATED FOETAL CELL OF MATERNAL BLOOD (75) Inventor: Patrizia Paterlini-Brechot, Paris (FR) (73) Assignees: Institut National de la Sante et de la